It's a dynamic process influenced by biology, lifestyle, medical history, and the consistency of support around you
Studies in patients with type 2 diabetes and obesity have demonstrated that the use of SGLT2 inhibitors, particularly empagliflozin, not only increases overall cancer risk but also significantly elevates the risk of bladder cancer [10, 108]
Yes, discuss persistent or worsening sexual dysfunction with your healthcare provider, especially if it affects your quality of life
Animals (Scientific Procedures) Act 1986 and following local ethical approval at University of Aberdeen
Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study
These agents bind directly to GLP-1 receptors on pancreatic beta cells, triggering a cascade of physiological responses that improve glycemic control in patients with type 2 diabetes mellitus